Salivary biglycan-neo-epitope-BGN(262): A novel surrogate biomarker for equine osteoarthritic sub-chondral bone sclerosis and to monitor the effect of short-term training and surface arena.
- DOI
- 10.1016/j.ocarto.2023.100354
- Published
- 2023 Jun
- Container
- Osteoarthritis and cartilage open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ocarto.2023.100354,
title = {Salivary biglycan-neo-epitope-BGN(262): A novel surrogate biomarker for equine osteoarthritic sub-chondral bone sclerosis and to monitor the effect of short-term training and surface arena.},
author = {Adepu S and Lord M and Hugoh Z and Nyström S and Mattsson-Hulten L and Abrahamsson-Aurell K and Lützelschwab C and Skiöldebrand E},
year = {2023},
journal = {Osteoarthritis and cartilage open},
doi = {10.1016/j.ocarto.2023.100354},
url = {https://doi.org/10.1016/j.ocarto.2023.100354}
}RIS
TY - JOUR TI - Salivary biglycan-neo-epitope-BGN(262): A novel surrogate biomarker for equine osteoarthritic sub-chondral bone sclerosis and to monitor the effect of short-term training and surface arena. AU - Adepu S AU - Lord M AU - Hugoh Z AU - Nyström S AU - Mattsson-Hulten L AU - Abrahamsson-Aurell K AU - Lützelschwab C AU - Skiöldebrand E PY - 2023 JO - Osteoarthritis and cartilage open DO - 10.1016/j.ocarto.2023.100354 UR - https://doi.org/10.1016/j.ocarto.2023.100354 ER -
APA
S, A., M, L., Z, H., S, N., L, M., K, A., C, L., & E, S. (2023). Salivary biglycan-neo-epitope-BGN(262): A novel surrogate biomarker for equine osteoarthritic sub-chondral bone sclerosis and to monitor the effect of short-term training and surface arena.. Osteoarthritis and cartilage open. https://doi.org/10.1016/j.ocarto.2023.100354
Source records
- pubmed · retrieved 2026-09-25T23:09:03.035Z